Median PFS for paclitaxel was @ months , ixabepilone was inferior to paclitaxel ( PFS , @ months ; hazard ratio , @ ; @ % CI , @ to @ ; P < @ ) , and nab-paclitaxel was not superior to paclitaxel ( PFS , @ months ; hazard ratio , @ ; @ % CI , @ to @ ; P = @ ) .